Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome

被引:330
作者
Meyers, CA
Albitar, M
Estey, E
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Neurooncol, Unit 431, Houston, TX 77030 USA
[2] Nicols Inst, Dept Hematopathol, San Juan Capistrano, CA USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
关键词
cytokines; cognition disorder; fatigue; leukemia;
D O I
10.1002/cncr.21234
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The objective of the current study was to assess the correlations between cognitive function, fatigue, quality of life, and circulating cytokine levels in patients with acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). Methods. Fifty-four patients with AML/MDS were seen for pretreatment evaluation of their cognitive function and symptoms. Fifty percent of the sample was reevaluated 1 month later, when response to protocol chemotherapy was assessed. Results. A significant proportion of patients had impaired cognitive function prior to the institution of chemotherapy. Sixty-five percent of patients also experienced significant fatigue. Levels of the circulating cytokines interleukin 1 (IL-1), IL-1 receptor antagonist (IL-1RA), IL-6, IL-8, and tumor necrosis factor-alpha (TNF-alpha) were elevated highly compared with normal controls. Higher IL-6 levels were associated with poorer executive function, whereas higher IL-8 levels were associated with better memory performance. IL-6, IL-1RA, and TNF-alpha levels were related to ratings of fatigue. Fatigue and cognitive dysfunction were unrelated. Hemoglobin levels were not associated significantly with either cognitive dysfunction or fatigue. Patients who obtained a complete response tended to have better fine motor control at baseline and lower circulating IL-1 levels. Treatment did not have a significant impact on cognition, although fatigue levels tended to increase. Conclusions. Patients with AML/MDS are highly symptomatic and experience cognitive impairment and fatigue before the initiation of their treatment. The current results indicated a correlation between these symptoms and levels of circulating cytokines, providing some support to the hypothesis that cancer-related symptoms are related at least in part to cytokine-immunologic activation. Elucidation of immunologic correlates of symptoms will allow for targeted interventions.
引用
收藏
页码:788 / 793
页数:6
相关论文
共 31 条
[1]   Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma [J].
Ahles, TA ;
Saykin, AJ ;
Furstenberg, CT ;
Cole, B ;
Mott, LA ;
Skalla, K ;
Whedon, MB ;
Bivens, S ;
Mitchell, T ;
Greenberg, ER ;
Silberfarb, PM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :485-493
[2]  
[Anonymous], 2004, Neuropsychological Assessment
[3]   Hopkins Verbal Learning Test Revised: Normative data and analysis of inter-form and test-retest reliability [J].
Benedict, RHB ;
Schretlen, D ;
Groninger, L ;
Brandt, J .
CLINICAL NEUROPSYCHOLOGIST, 1998, 12 (01) :43-55
[4]  
Benton A. L., 1989, Multilingual aphasia examination
[5]   CYTOKINE MODULATION OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA SECRETION FROM ACUTE MYELOGENOUS LEUKEMIA BLAST CELLS IN-VITRO [J].
BRUSERUD, O ;
NESTHUS, I ;
BUHRING, HJ ;
PAWELEC, G .
LEUKEMIA RESEARCH, 1995, 19 (01) :15-22
[6]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[7]   Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms [J].
Cleeland, CS ;
Bennett, GJ ;
Dantzer, R ;
Dougherty, PM ;
Dunn, AJ ;
Meyers, CA ;
Miller, AH ;
Payne, R ;
Reuben, JM ;
Wang, XS ;
Lee, BN .
CANCER, 2003, 97 (11) :2919-2925
[8]  
Cohen J., 1988, STAT POWER ANAL BEHA
[9]  
Cummings JL, 1990, SUBCORTICAL DEMENTIA
[10]  
DANTZER R, 1992, PERG S NEUR, V5, P135